Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOCANNATO: Preoperative Tocotrienol in Breast Cancer
NCT04496492Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Feb 2016
- Primary completion
- Feb 2016
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in breast cancer, sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Primary endpoints: Changes in blood oxidant capacity at 4 weeks, Changes in blood antioxidant capacity at 4 weeks and 4 more. Started Feb 2016; status: completed.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04496492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04496492.